Morgan Stanley’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$760K Sell
837,463
-131,318
-14% -$119K ﹤0.01% 5247
2025
Q1
$438K Buy
968,781
+308,720
+47% +$139K ﹤0.01% 5390
2024
Q4
$332K Sell
660,061
-188,230
-22% -$94.6K ﹤0.01% 5587
2024
Q3
$768K Buy
848,291
+321,662
+61% +$291K ﹤0.01% 5192
2024
Q2
$525K Buy
526,629
+67,932
+15% +$67.7K ﹤0.01% 5273
2024
Q1
$679K Sell
458,697
-496,435
-52% -$735K ﹤0.01% 5170
2023
Q4
$1.04M Buy
955,132
+677,316
+244% +$738K ﹤0.01% 5270
2023
Q3
$328K Buy
277,816
+125,587
+82% +$148K ﹤0.01% 5352
2023
Q2
$215K Sell
152,229
-153,891
-50% -$217K ﹤0.01% 5621
2023
Q1
$459K Buy
306,120
+174,327
+132% +$261K ﹤0.01% 5303
2022
Q4
$154K Buy
131,793
+69,231
+111% +$81K ﹤0.01% 5776
2022
Q3
$70K Sell
62,562
-66,343
-51% -$74.2K ﹤0.01% 6247
2022
Q2
$203K Sell
128,905
-115,250
-47% -$181K ﹤0.01% 5884
2022
Q1
$376K Sell
244,155
-284,402
-54% -$438K ﹤0.01% 5573
2021
Q4
$1.3M Buy
528,557
+403,214
+322% +$988K ﹤0.01% 4895
2021
Q3
$316K Sell
125,343
-3,419
-3% -$8.62K ﹤0.01% 5749
2021
Q2
$367K Buy
128,762
+18,235
+16% +$52K ﹤0.01% 5712
2021
Q1
$259K Sell
110,527
-19,143
-15% -$44.9K ﹤0.01% 5504
2020
Q4
$228K Buy
129,670
+76,287
+143% +$134K ﹤0.01% 5527
2020
Q3
$50K Sell
53,383
-31,163
-37% -$29.2K ﹤0.01% 5725
2020
Q2
$73K Buy
84,546
+26,198
+45% +$22.6K ﹤0.01% 5535
2020
Q1
$48K Sell
58,348
-138,976
-70% -$114K ﹤0.01% 5476
2019
Q4
$175K Buy
197,324
+119,302
+153% +$106K ﹤0.01% 5466
2019
Q3
$76K Buy
78,022
+31,143
+66% +$30.3K ﹤0.01% 5541
2019
Q2
$51K Sell
46,879
-18,584
-28% -$20.2K ﹤0.01% 5595
2019
Q1
$85K Sell
65,463
-115,991
-64% -$151K ﹤0.01% 5463
2018
Q4
$166K Sell
181,454
-46,700
-20% -$42.7K ﹤0.01% 5356
2018
Q3
$469K Sell
228,154
-48,933
-18% -$101K ﹤0.01% 5040
2018
Q2
$499K Buy
277,087
+1,990
+0.7% +$3.58K ﹤0.01% 5098
2018
Q1
$648K Sell
275,097
-18,315
-6% -$43.1K ﹤0.01% 4842
2017
Q4
$552K Buy
293,412
+107,495
+58% +$202K ﹤0.01% 4919
2017
Q3
$461K Buy
185,917
+71,593
+63% +$178K ﹤0.01% 4925
2017
Q2
$315K Sell
114,324
-54,585
-32% -$150K ﹤0.01% 5080
2017
Q1
$509K Sell
168,909
-69,739
-29% -$210K ﹤0.01% 4826
2016
Q4
$754K Buy
238,648
+215,322
+923% +$680K ﹤0.01% 4664
2016
Q3
$80K Buy
23,326
+11,281
+94% +$38.7K ﹤0.01% 5400
2016
Q2
$28K Buy
12,045
+7,290
+153% +$16.9K ﹤0.01% 5735
2016
Q1
$12K Sell
4,755
-23,190
-83% -$58.5K ﹤0.01% 6082
2015
Q4
$92K Buy
27,945
+10,095
+57% +$33.2K ﹤0.01% 5452
2015
Q3
$43K Sell
17,850
-88,803
-83% -$214K ﹤0.01% 5791
2015
Q2
$313K Buy
106,653
+60,570
+131% +$178K ﹤0.01% 4995
2015
Q1
$185K Sell
46,083
-81,674
-64% -$328K ﹤0.01% 5252
2014
Q4
$384K Sell
127,757
-96,913
-43% -$291K ﹤0.01% 4866
2014
Q3
$570K Sell
224,670
-88,184
-28% -$224K ﹤0.01% 4481
2014
Q2
$770K Sell
312,854
-5,467
-2% -$13.5K ﹤0.01% 4264
2014
Q1
$845K Buy
318,321
+196,106
+160% +$521K ﹤0.01% 4137
2013
Q4
$355K Buy
122,215
+84,267
+222% +$245K ﹤0.01% 4705
2013
Q3
$116K Buy
37,948
+20,266
+115% +$61.9K ﹤0.01% 5056
2013
Q2
$57K Buy
+17,682
New +$57K ﹤0.01% 5184